JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
Recursion Pharmaceuticals
RXRX
$2.56B
| $10.8M | ﹤0.01% |
1,082,105
+701,295
| +184% | +$7.81M |
2021 Q2
11 quarters
|
|
2352
PUT
Cigna
CI
$71.7B
| $10.8M | ﹤0.01% |
29,700
+25,400
| +591% | +$8.36M |
2021 Q3
10 quarters
|
|
2353
Hawkins
HWKN
$2.76B
| $10.8M | ﹤0.01% |
140,250
+18,806
| +15% | +$1.29M |
2016 Q2
31 quarters
|
|
2354
Doximity
DOCS
$5.09B
| $10.8M | ﹤0.01% |
400,069
+32,489
| +9% | +$926K |
2021 Q2
11 quarters
|
|
2355
NCR Voyix
VYX
$944M
| $10.7M | ﹤0.01% |
850,931
+548,515
| +181% | +$7.9M |
2013 Q2
43 quarters
|
|
2356
Pediatrix Medical
MD
$2.12B
| $10.7M | ﹤0.01% |
1,070,059
+935,774
| +697% | +$8.71M |
2013 Q2
43 quarters
|
|
|
SCHQ
2357
Schwab Long-Term US Treasury ETF
SCHQ
$901M
| $10.7M | ﹤0.01% |
318,189
-21,042
| -6% | -$709K |
2023 Q3
2 quarters
|
|
2358
Arcturus Therapeutics
ARCT
$417M
| $10.7M | ﹤0.01% |
317,551
-5,268
| -2% | -$187K |
2019 Q2
19 quarters
|
|
|
OKLO
2359
Oklo
OKLO
$6.69B
| $10.7M | ﹤0.01% |
936,643
-793,892
| -46% | -$8.53M |
2023 Q1
4 quarters
|
|
2360
PUT
Cytokinetics
CYTK
$8.72B
| $10.7M | ﹤0.01% |
152,400
-361,500
| -70% | -$28M |
2023 Q4
1 quarter
|
|
2361
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.5B
| $10.6M | ﹤0.01% |
417,726
+34,909
| +9% | +$854K |
2022 Q4
5 quarters
|
|
2362
PUT
Abbott
ABT
$173B
| $10.6M | ﹤0.01% |
93,400
+48,000
| +106% | +$5.5M |
2017 Q3
26 quarters
|
|
2363
La-Z-Boy
LZB
$1.18B
| $10.6M | ﹤0.01% |
282,140
-10,285
| -4% | -$376K |
2013 Q2
43 quarters
|
|
2364
CALL
EOG Resources
EOG
$75.6B
| $10.6M | ﹤0.01% |
83,000
-5,200
| -6% | -$607K |
2022 Q2
7 quarters
|
|
2365
Titan International
TWI
$451M
| $10.6M | ﹤0.01% |
850,064
+491,427
| +137% | +$6.75M |
2021 Q2
11 quarters
|
|
2366
CALL
Marvell Technology
MRVL
$244B
| $10.5M | ﹤0.01% |
148,800
+110,800
| +292% | +$7.59M |
2022 Q1
8 quarters
|
|
2367
PUT
Bath & Body Works
BBWI
$3.52B
| $10.5M | ﹤0.01% |
210,800
+123,600
| +142% | +$5.55M |
2021 Q1
12 quarters
|
|
2368
CALL
Prudential Financial
PRU
$39.2B
| $10.5M | ﹤0.01% |
89,800
-100,600
| -53% | -$10.8M |
2021 Q1
12 quarters
|
|
2369
ODDITY Tech
ODD
$904M
| $10.5M | ﹤0.01% |
242,056
-70,739
| -23% | -$3.05M |
2023 Q3
2 quarters
|
|
2370
CrossAmerica Partners
CAPL
$828M
| $10.5M | ﹤0.01% |
461,063
-40,874
| -8% | -$922K |
2022 Q3
6 quarters
|
|
2371
Marten Transport
MRTN
$1.07B
| $10.5M | ﹤0.01% |
568,277
+37,955
| +7% | +$730K |
2015 Q4
33 quarters
|
|
|
BASE
2372
DELISTED
Couchbase
BASE
| $10.5M | ﹤0.01% |
398,925
+312,340
| +361% | +$8.12M |
2021 Q3
10 quarters
|
|
2373
US Physical Therapy
USPH
$1.25B
| $10.5M | ﹤0.01% |
92,944
-8,090
| -8% | -$808K |
2015 Q4
33 quarters
|
|
|
2374
PUT
Prudential Financial
PRU
$39.2B
| $10.5M | ﹤0.01% |
89,200
-202,500
| -69% | -$21.8M |
2021 Q1
12 quarters
|
|
|
TGNA
2375
DELISTED
TEGNA Inc
TGNA
| $10.5M | ﹤0.01% |
700,799
+96,805
| +16% | +$1.44M |
2013 Q2
43 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.